372 related articles for article (PubMed ID: 12846004)
1. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
3. Inducible cyclooxygenase may have anti-inflammatory properties.
Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 plays a central role in the genesis of pancreatitis and associated lung injury.
O'Brien G; Shields CJ; Winter DC; Dillon JP; Kirwan WO; Redmond HP
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):126-9. PubMed ID: 15730936
[TBL] [Abstract][Full Text] [Related]
5. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
6. Products of cyclooxygenase-2 catalysis regulate postoperative bowel motility.
Josephs MD; Cheng G; Ksontini R; Moldawer LL; Hocking MP
J Surg Res; 1999 Sep; 86(1):50-4. PubMed ID: 10452868
[TBL] [Abstract][Full Text] [Related]
7. [Effects of cyclooxygenase-2 on formation and healing of acetic acid-induced gastric ulcer in rats].
Shen X
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1380-3. PubMed ID: 11930633
[TBL] [Abstract][Full Text] [Related]
8. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
9. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading.
Li J; Burr DB; Turner CH
Calcif Tissue Int; 2002 Apr; 70(4):320-9. PubMed ID: 12004337
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
Oka T; Shearer T; Azuma M
Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
[TBL] [Abstract][Full Text] [Related]
11. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration.
Salzberg-Brenhouse HC; Chen EY; Emerich DF; Baldwin S; Hogeland K; Ranelli S; Lafreniere D; Perdomo B; Novak L; Kladis T; Fu K; Basile AS; Kordower JH; Bartus RT
J Pharmacol Exp Ther; 2003 Jul; 306(1):218-28. PubMed ID: 12676885
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
[TBL] [Abstract][Full Text] [Related]
15. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by nimesulide of prostaglandin production in rat macrophages.
Taniguchi Y; Yokoyama K; Ikesue A; Noda K; Debuchi H; Nakamura T; Toda A; Shimeno H
Drugs Exp Clin Res; 1998; 24(1):17-27. PubMed ID: 9604145
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M
Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury.
Song AM; Bhagat L; Singh VP; Van Acker GG; Steer ML; Saluja AK
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1166-74. PubMed ID: 12381531
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclooxygenase-2 decreases DNA synthesis induced by platelet-derived growth factor in Swiss 3T3 fibroblasts.
Castaño E; Bartrons R; Gil J
J Pharmacol Exp Ther; 2000 May; 293(2):509-13. PubMed ID: 10773022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
